Gland Pharma Limited in UTI - Long Term Advantage Fund Series VII · equitylore

Gland Pharma Limited · in UTI - Long Term Advantage Fund Series VII

Gland Pharma Limited in UTI - Long Term Advantage Fund Series VII

Held in 1 of the fund’s 41 disclosed months. Still held as of Aug 2021.

Current weight

0.60%

₹1.2 Cr in Aug 2021

Peak weight: 0.60%; Aug 2021
First held: Aug 2021; one continuous spell
Shares: 3,021; Aug 2021

Weight over time

Share of the fund's portfolio each month. A gap is a month the fund disclosed without this stock.

Weight of Gland Pharma Limited in UTI - Long Term Advantage Fund Series VII, Mar 2018 to Aug 2021.

Entries and exits

New entered Aug 2021still held1 months · peak 0.60%

Every month

Weight, value and quantity by month
Month	Weight	Value	Shares	Δ shares
Aug 2021	0.60%	₹1.2 Cr	3,021
Jul 2021	not held
Jun 2021	not held
May 2021	not held
Apr 2021	not held
Mar 2021	not held
Feb 2021	not held
Jan 2021	not held
Dec 2020	not held